Literature DB >> 10954563

Follicular dendritic cells and dissemination of Creutzfeldt-Jakob disease.

L Manuelidis1, I Zaitsev, P Koni, Z Y Lu, R A Flavell, W Fritch.   

Abstract

The contribution of immune system cells to the propagation of transmissible encephalopathies is not well understood. To determine how follicular dendritic cells (FDC) may act, we challenged lymphotoxin beta null and wild-type (wt) controls with a Creutzfeldt-Jakob disease (CJD) agent. There was only a small difference in incubation time to clinical disease even after peripheral challenge with low infectious doses (31 in a total of 410 days). Brain pathology with extensive microglial infiltration, identified by keratan sulfate, as well as astrocytic hypertrophy, was also equivalent in all groups despite the fact that null mice had neither FDC nor splenic metallophilic macrophages that filter particulate antigen. Because FDC accumulate pathologic prion protein (PrP) in infected but not wt mice, we studied the cellular distribution of PrP by confocal microscopy. The majority of pathologic PrP collected on the plasma membrane of FDC, as identified by the Ca(+2)-binding protein S100A. This surface distribution suggested that agent aggregated with pathologic PrP might spread by cell-to-cell contacts. While several types of leukocytes may be involved in agent dissemination, cells of myeloid lineage were found to be infectious. Moreover, perivascular tracks of microglia and abnormal PrP after intraperitoneal inoculation were consistent with hematogenous spread. In summary, FDC are not required for CJD agent spread from the periphery, although FDC may enhance spread through surface accumulation of pathologic PrP. While it is still not clear where the infectious agent replicates, macrophages can sequester appreciable levels of infectivity and hence act as reservoirs for prolonged latent infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10954563      PMCID: PMC116374          DOI: 10.1128/jvi.74.18.8614-8622.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Role of spleen macrophages in the clearance of scrapie agent early in pathogenesis.

Authors:  V Beringue; M Demoy; C I Lasmézas; B Gouritin; C Weingarten; J P Deslys; J P Andreux; P Couvreur; D Dormont
Journal:  J Pathol       Date:  2000-03       Impact factor: 7.996

Review 2.  Potential involvement of retroviral elements in human dementias.

Authors:  L Manuelidis; G Murdoch; E E Manuelidis
Journal:  Ciba Found Symp       Date:  1988

3.  Temporal distribution of transmissible mink encephalopathy virus in mink inoculated subcutaneously.

Authors:  W J Hadlow; R E Race; R C Kennedy
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

4.  Pathogenesis of scrapie virus infection in the mouse.

Authors:  C M Eklund; R C Kennedy; W J Hadlow
Journal:  J Infect Dis       Date:  1967-02       Impact factor: 5.226

5.  Transmission of Creutzfeldt-Jakob disease from human blood and urine into mice.

Authors:  J Tateishi
Journal:  Lancet       Date:  1985-11-09       Impact factor: 79.321

6.  Transmission to animals of Creutzfeldt-Jakob disease from human blood.

Authors:  E E Manuelidis; J H Kim; J R Mericangas; L Manuelidis
Journal:  Lancet       Date:  1985-10-19       Impact factor: 79.321

7.  Amyloid plaques in the brains of mice with Creutzfeldt-Jakob disease.

Authors:  J Tateishi; H Nagara; K Hikita; Y Sato
Journal:  Ann Neurol       Date:  1984-03       Impact factor: 10.422

8.  Viremia in experimental Creutzfeldt-Jakob disease.

Authors:  E E Manuelidis; E J Gorgacs; L Manuelidis
Journal:  Science       Date:  1978-06-02       Impact factor: 47.728

9.  Detection of prion protein mRNA in normal and scrapie-infected tissues and cell lines.

Authors:  B Caughey; R E Race; B Chesebro
Journal:  J Gen Virol       Date:  1988-03       Impact factor: 3.891

10.  Creutzfeldt-Jakob disease in mice: persistent viremia and preferential replication of virus in low-density lymphocytes.

Authors:  Y Kuroda; C J Gibbs; H L Amyx; D C Gajdusek
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

View more
  22 in total

1.  Neuroinvasion by a Creutzfeldt-Jakob disease agent in the absence of B cells and follicular dendritic cells.

Authors:  M J Shlomchik; K Radebold; N Duclos; L Manuelidis
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

2.  Rapid prion neuroinvasion following tongue infection.

Authors:  Jason C Bartz; Anthony E Kincaid; Richard A Bessen
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Virus-like interference in the latency and prevention of Creutzfeldt-Jakob disease.

Authors:  Laura Manuelidis; Zhi Yun Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-11       Impact factor: 11.205

Review 4.  Prion diseases: current understanding of epidemiology and pathogenesis, and therapeutic advances.

Authors:  Maria Caramelli; Giuseppe Ru; Pierluigi Acutis; Gianluigi Forloni
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

5.  Efficient lymphoreticular prion propagation requires PrP(c) in stromal and hematopoietic cells.

Authors:  P S Kaeser; M A Klein; P Schwarz; A Aguzzi
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

6.  Lymph nodal prion replication and neuroinvasion in mice devoid of follicular dendritic cells.

Authors:  Marco Prinz; Fabio Montrasio; Michael A Klein; Petra Schwarz; Josef Priller; Bernhard Odermatt; Klaus Pfeffer; Adriano Aguzzi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-15       Impact factor: 11.205

7.  Retrograde transport of transmissible mink encephalopathy within descending motor tracts.

Authors:  Jason C Bartz; Anthony E Kincaid; Richard A Bessen
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

8.  Infected splenic dendritic cells are sufficient for prion transmission to the CNS in mouse scrapie.

Authors:  P Aucouturier; F Geissmann; D Damotte; G P Saborio; H C Meeker; R Kascsak; R Kascsak; R I Carp; T Wisniewski
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

9.  Strain-specific viral properties of variant Creutzfeldt-Jakob disease (vCJD) are encoded by the agent and not by host prion protein.

Authors:  Laura Manuelidis; Ying Liu; Brian Mullins
Journal:  J Cell Biochem       Date:  2009-02-01       Impact factor: 4.429

10.  The kuru infectious agent is a unique geographic isolate distinct from Creutzfeldt-Jakob disease and scrapie agents.

Authors:  Laura Manuelidis; Trisha Chakrabarty; Kohtaro Miyazawa; Nana-Aba Nduom; Kaitlin Emmerling
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.